An Official Website of the United States Government
Company Information:
Name:
XERIS PHARMACEUTICALS, INC.
Address:
3925 West Braker Lane, 3rd Floor
Austin, TX 78759-5316
Austin, TX 78759-5316
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
IMPROVED HYPOGLYCEMIA RESCUE DEVICE
Award Year / Program / Phase:
2009 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
John Kinzell
Award Amount:
$157,478.00
Abstract:
DESCRIPTION (provided by applicant): The objective of this program is to develop of a clinical prototype, semi-solid drug formulation and auto-injector pen that deliver microliter volumes of a glucagon dose without reconstitution for hypoglycemic emergenci
es. To assess the feasibility of this… More
Improved Hypoglycemia Rescue Device
Award Year / Program / Phase:
2011 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
John Kinzell – 415-472-4623
Award Amount:
$994,123.00
Abstract:
DESCRIPTION (provided by applicant): The objective of this project is to demonstrate the safety, pharmacokinetics and initial efficacy of a ready-to-use Glucagon Rescue Pen that will deliver a very low volume dose of a glucagon without reconstitution for hypoglycemic emergencies. To execute on this… More
Clinical Development of a Stable Glucagon Formulation for Bi-hormonal Pump
Award Year / Program / Phase:
2012 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Steven Prestrelski – 510-742-9700
Award Amount:
$343,124.00
Abstract:
DESCRIPTION (provided by applicant): The objective of this program is to further the development of a novel, stable, non-aqueous glucagon formulation as an integral component of a bi-hormonal (insulin-glucagon) pump system for treatment of persons with diabetes. The addition of glucagon to the… More